Ground Swell Capital, LLC P Lx Pharma Inc. Transaction History

Ground Swell Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$0.12 - $0.3 $1,178 - $2,946	-9,822 Reduced 4.49%	208,998 $27,000
Q4 2022 Feb 13, 2023	BUY	$0.15 - $0.63 $25,483 - $107,030	169,889 Added 347.2%	218,820 $35,000
Q2 2022 Aug 11, 2022	BUY	$1.9 - $4.18 $33,783 - $74,324	17,781 Added 57.08%	48,931 $119,000
Q1 2022 May 10, 2022	SELL	$3.54 - $8.3 $18,609 - $43,633	-5,257 Reduced 14.44%	31,150 $126,000
Q4 2021 Feb 09, 2022	BUY	$7.69 - $19.66 $47,839 - $122,304	6,221 Added 20.61%	36,407 $292,000

Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $368,872 - $642,358	30,186 New	30,186 $583,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ground Swell Capital, LLC with notifications on news.